Abstract Purpose of Review Infectious diseases represent up to 12% of all deaths in people
with diabetes mellitus (DM). The development and progression of DM generate a chronic …

The gut microbiome has emerged as a major character in the context of hematopoietic stem
cell transplantation. The biology underpinning this relationship is still to be defined …

Oral mucositis (OM) is a common debilitating dose-limiting toxicity of cancer treatment,
including hematopoietic stem cell transplantation (HSCT). We hypothesized that the oral …

The literature of human and other host-associated microbiome studies is expanding rapidly,
but systematic comparisons among published results of host-associated microbiome …

Acute graft-versus-host disease (aGVHD) is one of the major causes of death after
allogeneic hematopoietic stem cell transplantation (allo-HSCT). Recently, aGVHD onset was …

The human microbiota heavily influences most vital aspects of human physiology including
organ transplantation outcomes and transplant rejection risk. A variety of organ …

Intestinal microbiota (IM) diversity and composition regulates host immunity and affects
outcomes after allogeneic stem cell transplantation (allo-HSCT). We evaluated if the oral …

Cancer is responsible for~ 18 million deaths globally each year, representing a major cause
of death. Several types of therapy strategies such as radiotherapy, chemotherapy and more …

Allogeneic hematopoietic stem cell transplantation (allo-HSCT) is an evidence based-
cellular immunotherapy for hematological malignancies. Immune reactions not only promote …

Introduction Autologous hematopoietic cell transplantation (AHCT) is a well-established
treatment for lymphoma. Unintended effects of this therapy include oral mucositis (OM) and …